Valuation: Virbac

Market Cap 293.22Cr 333.4Cr 272.4Cr 250.54Cr 469.84Cr 32TCr 478.26Cr 3.26TCr 1.27TCr 16TCr 1.25TCr 1.22TCr 55TCr P/E 2026 *
17.2x
P/E 2027 * 15.5x
Enterprise Value 305.9Cr 347.81Cr 284.18Cr 261.36Cr 490.15Cr 34TCr 498.93Cr 3.4TCr 1.33TCr 16TCr 1.31TCr 1.28TCr 57TCr EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.83x
Free-Float
49.03%
Yield 2026 *
0.49%
Yield 2027 * 0.58%
1 day-6.07%
1 week-6.07%
Current month-6.07%
1 month-6.07%
3 months-0.39%
6 months-12.16%
Current year-12.16%
1 week 382.75
Extreme 382.75
413.75
1 month 382.75
Extreme 382.75
413.75
Current year 382.75
Extreme 382.75
413.75
1 year 382.75
Extreme 382.75
436.32
3 years 288
Extreme 288
436.32
5 years 288
Extreme 288
436.32
10 years 131
Extreme 131
436.32
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-6.07%-6.07% - - 334.65Cr
-0.26%-3.69%-51.73%-60.09% 3.11TCr
-1.60%-4.70%+64.65%+105.23% 1.27TCr
+1.84%+5.45%-19.46%+1.84% 371.56Cr
+2.30%-5.32%+32.72%+12.78% 182.34Cr
-1.62%+2.76%-10.80%+23.71% 185.7Cr
+0.74%-1.42%+14.23%+125.66% 137.15Cr
+1.01%-1.29%-24.79%-13.46% 106.75Cr
+0.78%-0.77%-17.26%-47.86% 97Cr
-1.26%-2.48%-8.76%-21.25% 95Cr
Average -0.48%+1.07%-2.36%+14.06% 616.81Cr
Weighted average by Cap. -0.83%+0.14%-15.41%-6.69%

Financials

2026 *2027 *
Net sales 154.98Cr 176.22Cr 143.98Cr 132.42Cr 248.33Cr 17TCr 252.79Cr 1.72TCr 671.55Cr 8.32TCr 661.56Cr 647.25Cr 29TCr 164.65Cr 187.21Cr 152.96Cr 140.68Cr 263.82Cr 18TCr 268.55Cr 1.83TCr 713.44Cr 8.84TCr 702.82Cr 687.62Cr 31TCr
Net income 17Cr 19Cr 16Cr 15Cr 27Cr 1.88TCr 28Cr 190.11Cr 74Cr 919.08Cr 73Cr 71Cr 3.19TCr 19Cr 22Cr 18Cr 16Cr 30Cr 2.09TCr 31Cr 211.01Cr 82Cr 1.02TCr 81Cr 79Cr 3.54TCr
Net Debt 13Cr 14Cr 12Cr 11Cr 20Cr 1.4TCr 21Cr 140.8Cr 55Cr 680.72Cr 54Cr 53Cr 2.36TCr 7.52Cr 8.55Cr 6.98Cr 6.42Cr 12Cr 827.58Cr 12Cr 83Cr 33Cr 403.66Cr 32Cr 31Cr 1.4TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
334.50EUR
Average target price
412.00EUR
Spread / Average Target
+23.17%

Quarterly revenue - Rate of surprise